SecBot SecBot

PREVENT DIABETES Act

S. 4094 Sen. Tim Scott (R-SC) In committee
Bill text PDF
  1. Introduced Apr 10
  2. Committee Apr 10
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Apr 10, 2024Next: Senate vote
933d ago Apr 10, 2024: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 2 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill makes the Medicare Diabetes Prevention Program a permanent, covered benefit under Medicare Part B, replacing the current pilot program. It defines the services, eligible individuals, and suppliers, and establishes a payment structure.

Sec. 2, Medicare Diabetes Prevention Program: This section adds diabetes prevention program services as a covered benefit under Medicare Part B starting January 1, 2025. Services are structured behavioral health sessions following a CDC-approved curriculum for eligible individuals (those with Part A and B, no diabetes diagnosis, no end-stage renal disease, and meeting other criteria). There is no lifetime limit on participation. It also defines 'diabetes prevention program suppliers' as entities recognized by the CDC's Diabetes Prevention Recognition Program, and sets enrollment, documentation, inspection, and termination requirements for them.

Sec. 3, Sunset of MDPP Expanded Model: No payments will be made under the existing Medicare Diabetes Prevention Program Expanded Model pilot program after January 1, 2025.

Sec. 4, Update to Regulations: The Secretary of Health and Human Services must update specific federal regulations by November 30, 2024, to align with the new program.

Sec. 5, Report: By January 1, 2028, the Secretary must report to Congress on the program's impact, including participation rates, weight loss, health outcomes, and diagnoses and costs related to type 2 diabetes.

Summary of the bill text as introduced in Senate (Apr 10, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.